Analysis Castle Biosciences Inc (CSTL)
6/3/2024
Analysis of Castle Biosciences Inc (CSTL)
Castle Biosciences Inc (CSTL) is showing some interesting trends based on the recent data. Here is a brief analysis:1. **Price Movement**: The stock price has been fluctuating in the recent days, with the closing price ranging from $23.24 to $24.53.
2. **Relative Strength Index (RSI)**: The RSI values have been in the range of 48.55 to 67.49, indicating that the stock has been neither oversold nor overbought recently.
3. **Moving Average Convergence Divergence (MACD)**: The MACD indicator has been positive, with values ranging from 0.59 to 1.01. The MACD line has been above the signal line, suggesting a bullish trend.
4. **Moving Averages (MA)**: The Simple Moving Average (SMA) and Exponential Moving Average (EMA) have been close to each other, indicating a stable trend.
5. **Weighted Moving Average (WMA)**: The Weighted Moving Average has also been consistent with the other moving averages, supporting the stability of the trend.
Overall, based on the RSI, MACD, and moving averages, Castle Biosciences Inc seems to be in a stable position with a potential for a bullish trend. However, it is always recommended to conduct further analysis and consider other factors before making any investment decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
Overall, the analysts are forecasting moderate growth in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current fiscal year.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is 5.2%.
3. Current Year: The estimated growth rate for the current year is 7.6%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 9.7%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. It indicates a steady but slightly slower growth trajectory in the future.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
Based on these forecasts, it appears that the analysts are generally optimistic about the future price of the security paper, with a median forecast above the current price. However, there is a wide range of predictions, from $164 to $275, indicating some uncertainty in the market.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a specific company. Here are some key points from the data:1. Financials:
- Cash Flow: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320.
- Balance Sheet: Total cash on a quarterly basis is $67,150,000,128, while total debt is $104,590,000,128. The current ratio is 1.037, and the total debt to equity ratio is 140.968.
- Profit Margin: The profit margin is 26.306%.
- Income Statement: EBITDA is $131,393,000,000, with a revenue of $381,623,009,280 for the TTM period. Diluted EPS is $6.43, and net income to common for TTM is $100,389,003,264.
- Operating Margin: The operating margin is 30.743%.
- Return on Assets and Equity: The return on assets for TTM is 22.07399%, and the return on equity is 147.25%.
2. Stock Statistics:
- Short Interest: Short ratio is 1.53, with 99,287,450 shares shorted.
- Shares Information: Float shares are 15,308,320,742, and shares outstanding are 15,334,099,968.
- Institutional Holdings: Institutions hold 57.589% of shares, while insiders hold 5.22%.
- Short Percent: Short percent of shares outstanding is 0.65%.
3. Valuation Metrics:
- PEG Ratio: 26.319502
- Price Ratios: Forward PE is 26.319502, trailing PE is 29.59409, price to book is 39.3405, and price to sales is 7.646095.
- Enterprise Value: $2,950,762,332,160
4. Stock Price Summary:
- Beta: 1.264
- Moving Averages: 50-day MA is 176.2646, and 200-day MA is 181.0429.
- 52-Week Range: Low of 164.08, high of 199.62, with a change of 6.853%.
5. Dividends and Splits:
- Dividend Information: Forward annual dividend rate is $1, with a yield of 0.5255%. Trailing annual dividend rate is $0.97, with a yield of 0.5097%.
- Dividend Dates: Dividend date is 2024-05-16, ex-dividend date is 2024-05-10.
- Split Information: Last split date was 2020-08-31, with a 4-for-1 split.
Income statement 💸
These are the revenue figures. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing a healthy growth in profitability.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally increased over the years, indicating growth in shareholder value.
7. The company has been able to maintain a stable number of outstanding shares, which is important for EPS calculations.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a healthy growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2022 at $217,350,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There has been a consistent increase in shareholders' equity, indicating a positive trend in the company's financial health.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has been consistently higher than free cash flow, indicating that the company is generating sufficient cash from its core operations.
3. The company has been paying a significant amount in income taxes each year, with the highest amount paid in 2021.
4. The end cash position has also been fluctuating, with the highest value recorded in 2020 and the lowest in 2022.
5. The company has been actively involved in financing activities, including common stock repurchases, debt issuances, and dividend payments.
6. Investing activities have also been significant, with the company making acquisitions, selling investments, and investing in capital expenditures.
7. Overall, the company's financial performance seems to be stable, with fluctuations in certain areas that may require further analysis and attention.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low estimate of $5.95 to a high estimate of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for both the upcoming quarters and fiscal years.
MACD of CSTL
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
